4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-004201
General Counsel sold 10,800 shares at $7.42 ($80,146)
From the SEC's structured data for this filing
Trades in this filing
MOORE JOHN R · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-16 | Sale : show line 1 in the form | −10,800 | $7.42 | $80,146 | 3,000 | D |
| Open-market sales · 10,800 sh · avg $7.42 · $80,146 | ||||||
Loading xslF345X03/primarydocument.xml…